Hypopharyngeal Cancer

Our multidisciplinary team has extensive experience in diagnosing and treating hypopharyngeal cancer, which develops in the hypopharynx, the bottom part of the throat. Our surgeons, medical oncologists, and radiation oncologists collaborate to create a treatment plan based on the location of the tumor, its size, and how far it has spread. The goal is to find the right combination of treatments to destroy hypopharyngeal cancer while preserving organ function.

Clinical Trials and Research Studies

Phase 1

A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

Learn More

Phase 5

First-in-human open-label dose-escalation trial with expansion cohorts to evaluate safety of GEN1046 in subjects with malignant solid tumors

Learn More

Phase 1

A Phase 1 Open Label Multi-Arm Multicenter Study of MK-4830 as Monotherapy and in Combination with Pembrolizumab for Participants with Advanced Solid Tumors

Learn More

Phase 6

Site for Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Learn More